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ABSTRACT
Objectives: Candida albicans is known to produce gliotoxin, which has several prominent biological
effects, including immunosuppression, interference with host defenses may arise from the effects of
this toxin on leukocyte structure and function.
Methods: Flow cytometric analysis revealed that polymorphonuclear leukocytes (PMN) were
more sensitive to gliotoxin than were mononuclear cells. Structural and various functional aspects
ofPMN exposed to gliotoxin were studied.
Results: Gliotoxin at (1 pg/mL) did not affect the viability but did diminish PMN chemotaxis and
reduced their ability to ingest particles. Other functional aberrations included decreased nitroblue
tetrazolium dye reduction, decreased superoxide production, and release of lactoferrin suggesting
by degranulation. Gliotoxin also affected the ability ofPMN to kill Escherichia coli.
Conclusions: This study suggests a previously unrecognized potential virulence factor of C. albi-
cans that could contribute to persistence of yeast colonization or recurrence of symptomatic infec-
tion through diminished host resistance. Infect. Dis. Obstet. Gynecol. 6:168-175, 1998.
(C) 1998 Wiley-Liss, Inc.
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ucocutaneous candidiasis is a common prob-
lem among immunocompromised patients,
including those with acquired immunodeficiency
syndrome (AIDS), but it can also occur in individu-
als without known immune defects. Virulence at-
tributes of Candida albicans, particularly those that
may suppress the immune system, remain incom-
pletely investigated. Several reports describe prod-
ucts of Candida that may contribute to its virulence,
including a protease and cell wall mannans that
have been reported to interfere with neutrophil
function, z In addition, a crude product of candidal
hyphae was shown to prevent normal superoxide
production by stimulated neutrophils.
3
A new dimension was added to study Candida
virulence when we found that clinical isolates of
this organism produced gliotoxin,4 an epipolythio-
dioxopiperazine mycotoxin. This class of com-
pounds is known for various biological actions, in-
cluding antibacterial, antiviral, and immunosup-
pressive activities, s We subsequently analyzed
vaginal samples of three women severely symp-
tomatic for vaginal candidiasis and found that they
contained significant levels of gliotoxin.6 We rea-
soned that in vivo production of gliotoxin by C.
albicans may contribute to its virulence and chro-
nicity of disease by circumventing local host de-
fenses. In mucocutaneous candidiasis, polymor-
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phonuclear leukocytes (PMN) seemed to be crucial
as a prominent defense mechanism. This study was
undertaken to evaluate effect of gliotoxin on hu-
man PMN functions.
MATERIAL AND METHODS
Crystalline gliotoxin was purchased from Sigma
Chemical Company (St. Louis, MO). Purchased
gliotoxin was found identical to the toxin produced
by clinical isolates of C. albicans. 7 Stock solutions
were prepared in methanol and further diluted in
RPMI or phosphate-buffered saline with glucose
(PBSG) to attain the desired final concentrations.
Preparation of whole heparinized blood for flow
cytometry used blood drawn from healthy volun-
teers. To 10 mL of whole blood, 14 mL of lysing
reagent (NH4C1, 8 g/L; KHCO3, 1.0 g/L, tetraso-
dium EDTA, 37.0 mg/mL, pH 7.3) was added,
mixed for 3 to 5 minutes, and centrifuged for 30
minutes at 300g at room temperature. The cell pel-
let was washed twice with phosphate-buffered sa-
line (PBS) and resuspended in 1 mL of PBS.
PMN preparations were obtained by gradient
centrifugation of whole blood through Mono-Poly
Resolving Medium (Flow Laboratories, McLean,
VA) according to the manufacturer’s directions.
The PMN layer was aspirated and delivered into
tubes containing calcium-free PBSG. Cell viability
(>95%) was confirmed with trypan blue dye exclu-
sion, and counts were made in a hemacytometer.
Dilutions of PMN were made in PBSG with
0.001M CaC1z and 0.1% gelatin (Sigma).
Flow cytometry employed a FACscan instru-
ment (Beckon Dickinson Immunocytometry Sys-
tems, Mountain View, CA). All analyses were per-
formed on Leucogate R (Beckon Dickinson, San
Jose, CA) antibody treated cells. Each analysis con-
sisted of a minimum of 5,000 gated events. Histo-
grams were contoured and visually inspected for
the presence of distinct populations Gates were
then chosen to incorporate all events associated
with distinct populations. These gates were used to
analyze all subsequent data sets. The effect of glio-
toxin on leukocytes was initially investigated by
exposing blood cells to high doses of gliotoxin (0.5-
500 lag/mL) in PBSG (pH 7.3) at a cell concentra-
tion of lxl06 leukocytes/mL at 37C for 30 min-
utes. At the end of the incubation period, 5 laL of
Leucogate antibody (Beckon Dickinson) was
added, and the labeling proceeded in the dark at
room temperature for 15 minutes, followed by flow
cytometric analysis.
Cell viability after gliotoxin exposure was dem-
onstrated both by trypan blue dye exclusion and by
flow cytometry of propidium iodide treated cells.
Leukocytes (1106 leukocytes/mL) were incu-
bated with gliotoxin diluted in PBSG or RPMI at
37C. Cells were exposed to 0.5-500 lag/mL of glio-
toxin, and samples were taken at different time
intervals ranging from 15 to 90 minutes. Samples
were further mixed with 5 mL of 0.0005% prop-
idium iodide (Sigma) and analyzed by flow cytom-
etry.
After determining the gliotoxin concentration (1
lag/mL), PMN chemotaxis was investigated in
modified Boyden chambers. Gliotoxin-treated
PMN (1 lag gliotoxin, 1106 PMN/mL) were acti-
vated with LPS-treated human serum (0.1 mg of
LPS to mL of human serum was incubated for 60
minutes at 37C). At the end of 30 minutes of in-
cubation, the pattern of migration ofPMN across a
polycarbonate filter (3 lain pore size) was evaluated
after Giemsa staining by light microscopy. Controls
consisted of PMN incubated without gliotoxin.
Particle ingestion by PMN was evaluated by up-
take of fluorescein-conjugated styrene beads (Flow
Cytometry Standards Corp., NC). The PMN
(l106/mL) were incubated for 15 minutes with
lag/mL gliotoxin and mixed with beads to achieve a
particle-to-cell ratio of 100:1. The mixture was
gently mixed on a rotating wheel, and aliquots
were removed at timed intervals. Aliquots were
centrifuged in medium containing 2% BSA, and
the cells recovered were resuspended in MEM
with 20 mM 2-N-morpholine propane sulfonic acid
with 10% fetal bovine serum. The fluorescence
due to ingested beads was measured by flow cy-
tometry.
Nitroblue tetrazolium (NBT) reduction was
used to measure respiratory burst activity. The
PMN (1106 cells/mL) were pretreated with
lag/mL gliotoxin (control cells remained untreated)
with stimulant consisting of the supernatant from
zymosan (Sigma) treated serum. One tenth of a
milliliter of NBT was added to the mixture and
incubated for 10-20 minutes, and the development
of color was monitored spectrophotometrically at
570 with 630 used as the reference wavelength.
Production of superoxide anion by gliotoxin-
treated or untreated cells was determined spectro-
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Fig. I. Flow cytometric analysis of human blood leukocytes. Flow cytometric analysis of peripheral blood collected from
healthy donors was performed in a FACscan flow cytometer. (A) Windows I, 2, and 3 represent lymphocytes, monocytes,
and PMN. The leukocyte populations are separated on the basis of forward vs side scatter. (B) Human leukocytes exposed
to 500 pg/mL-concentration of gliotoxin for 30 minutes showed a shift in PMN population from right to left on the forward
scatter axis and downward on the side scatter scale, consistent with these cells becoming smaller and less granular.
photometrically by reduction of cytochrome C as
described elsewhere. 8 Experiments were con-
ducted in sets of three tubes in which phorbol rny-
ristate acetate (PMA, 10 laL/5 mL) was used as an
activator forPMN superoxide production. The first
tube was a cell-free control that showed baseline
superoxide production from PMA, the second tube
contained superoxide dismutase (2 lag) with cells
and PMA to establish assay specificity, and the
third tube contained cells and PMA and was the
positive test. Cell concentration was l xl07 PMN in
mL of HEPES (N-2-Hydroxyethylpiperazine-N-
2-ethenesulfonic acid) buffered medium (HBM)
and 0.4 mL of cytochrome C (18.6 mg/mL). Tests
were performed in triplicate comparing cells
treated with 1 lag/mL g|iotoxin with untreated
cells. After mixing the compounds, all tubes were
incubated at 37C for 15-minute timed intervals
after which cells were removed by centrifugation
and the absorbance of the supernatant fluid was
read at 530 nm. Superoxide was calculated as fol-
lows: nm superoxide/106 PMN/h BAbs x 103/21
where 6Abs means the difference in absorbance
between the samples with and without superoxide
dismutase after subtracting time zero values from
each.
Intracellular killing of Escherichia coli by PMN
was determined by suspending 2.5x106 PMN in 0.1
mL of fetal calf serum and 0.3 mL HBS and con-
ditioning them for 5 minutes at 37C. Subse-
quently, 2107 E. coli contained in 0.1 mL of HBS
were added to each well. Aliquots were removed at
timed intervals and centrifuged at 150g for 5 min-
utes, and the supernatant fluid was removed. The
supernatant-containing bacteria that had not been
ingested (100 laL) were added to 9.9 mL of sterile
water, and dilutions were plated on nutrient agar.
The pellet that contained the PMN was suspended
in sterile water to lyse the cells and release viable
intracellular bacteria, which were enumerated by
viable plate count.
RESULTS
The effect of gliotoxin on the various types of leu-
kocytes in peripheral blood was tested by incubat-
ing 500 lag gliotoxin per mL of whole blood lysate
for 30 minutes at 37C. As illustrated by Figure 1,
the granulocyte population appeared more affected
(decreased forward scatter and decreased side scat-
ter) than either the mononuclear cell population or
the lymphocytes population. Thus, it appeared that
gliotoxin may have caused a decrease in granulo-
cyte size and granularity. To determine if the glio-
toxin-treated leukocytes were dying, viability was
measured by propidium iodide uptake. Gliotoxin
(0.5-500 lag/mL for 15-90 minutes at 37C) did not
appear to damage lymphocytes, whereas granulo-
cytes and monocytes were stained with propidium
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Fig. 2. Gliotoxin effect on leukocyte viability. Human leu-
kocytes were exposed to 500 IJg/mL of gliotoxin for 15 and
30 minutes. Viability was measured by propidium iodide
uptake. PMN were the most affected when compared with
lymphocytes and monocyte populations of the peripheral
blood.
iodide (Figure 2). After 30 minutes of exposure to
gliotoxin, 24% of granulocytes were stained with
propidium iodide and 9% of monocytes were
stained.
Because the granulocyte population, which con-
sists mainly of PMN, appeared to be the most sus-
ceptible to gliotoxin, subsequent studies focused
mainly on PMN that were isolated from healthy
donors by Ficoll-Hypaque density gradient cen-
trifugation. Isolated PMN exposed to gliotoxin
(500 lag/mL for 15-90 minutes at 37C) showed an
increase in propidium iodide uptake that was both
gliotoxin dose-dependent and time-dependent, as
shown by Figure 3. These results were corrobo-
rated by trypan blue dye exclusion that showed
that minimum cytocidal gliotoxin concentration ap-
peared to be greater than 1 lag/mL.
Gliotoxin concentration (1 lag/mL) was selected,
which did not have a cytocidal effect on PMN. To
systematically determine if gliotoxin could cause
functional aberration in PMN, several aspects of
phagocytic function in gliotoxin-treated (1 lag/mL)
and control PMN were investigated. The vigor of
chemotaxis in gliotoxin-treated PMN was evalu-
ated in Boyden chambers. Gliotoxin-treated (I lag/
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Fig. 3. Propidium iodide uptake measures by FL2 fluores-
cence. FL2 fluorescence (due to PI uptake) was increased by
increasing the incubation time of gliotoxin-treated (500 IJg/
mL) PMN. Panel A represents the unintoxicated PMN,
which do not show significant increases in FL2 fluorescence.
As the incubation time increases, more PMN are seen in the
FL2 region of panel B, which reprresents gliotoxin-treated
PMN.
mL) PMN migrated less effectively across the
membranes than untreated PMN, as shown in Fig-
ures 4A and 4B.
Phagocytic function depends in part on the abil-
ity of PMN to attach to and engulf particles. The
effect of gliotoxin on these aspects of phagocytosis
was determined by monitoring the uptake of fluo-
rescent styrene beads and measured by flow cy-
tometry. As shown in Figure 5, 40% of untreated
PMN engulfed particles within 90 minutes,
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Fig. 4. (A) Control (untreated) PMN migration. Migra-
tion pattern of untreated PMN across the polycarbonated
membrane was observed by staining the filter with Giemsa.
The stained membrane was placed on a glass slide with an
oil drop and a coverslip and observed under light micros-
copy. Clear channels represent the pores present in the
membrane. (B) Migration of gliotoxin-treated (I pg/mL)
PMN. PMN crossing the polycarbonate membranes were
quantitated and plotted for each of the donors participating
in this study.
whereas only 13% of cells treated with pg/mL of
gliotoxin/mL for 90 minutes ingested fluorescent
beads.
Actively phagocytic active cells increase their
oxidative metabolism resulting in the generation of
reactive oxygen species such as superoxide. The
increased reducing capacity of phagocytically ac-
tive leukocytes may be measured by nitroblue tet-
razolium dye reduction. Figure 6 shows that
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Fig. 5. Particle engulfment by gliotoxin-treated (I IJg/mL)
PMN. A PMN suspension (gliotoxin-treated [GT] and -un-
treated) was adjusted to Ix 106 cells/mL. The cells were
co-incubated with fluorescein-conjugated beads (I x 108
cells/mL) at 37C for 30 to 90 minutes. The effect of glio-
toxin on particle uptake by PMN was investigated by flow
cytometry.
complement-stimulated gliotoxin-treated (1 pg/mL
of gliotoxin for 10 minutes at 37C) PMN had di-
minished capacity for dye reduction compared with
stimulated control PMN.
The antibacterial mediator, superoxide anion,
was decreased when cells were pretreated with
gliotoxin, compared with untreated cells as shown
by Figure 7.
The final aspect of neutrophilic cell function
studied was intracellular bacterial killing. Viable E.
coli was used as the test organism, and PMN pre-
treated with gliotoxin or untreated control cells
were allowed to ingest and kill the test bacterium.
Whereas control PMN inactivated 79% of E. coli
within the first 30 minutes after mixing bacteria
and phagocytic cells, gliotoxin-treated cells failed
to kill any E. coli. By 90 minutes, control PMN had
killed 93% of the bacteria, and the gliotoxin-
treated PMN killed 79% of the bacterial challenge
(Figure 8).
DISCUSSION
Although the literature regarding the pathogenic
potential of Candida is extensive, our understand-
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Fig. 6. Metabolic stimulation of gliotoxin-treated (I Ig/
mL) PMN. NBT reduction by unstimulated (US) PMN, un-
stimulated gliotoxin-treated PMN, zymosan-stimulated (S)
PMN, and zymosan-stimulated gliotoxin-treated (S-GT)
PMN was measured spectrophotometrically at 570 nm
wavelength with a reference wavelength of 630 nm.
ing of specific virulence factors and their role in
pathogenesis remains limited. In mucocutaneous
candidiasis, PMN seemed to be crucial as a promi-
nent defense mechanism.9 Patients with few neu-
trophils or dysfunctional phagocytes are more sus-
ceptible to disease with Candida than individuals
with normal neutrophil function.
Interestingly, the results of this study suggest
that gliotoxin is more deleterious to PMN than
mononuclear cells or lymphocytes from peripheral
blood, as evidenced by propidium iodide staining.
This cytocidal effect, however, employed concen-
trations of gliotoxin that probably would not occur
in vivo.1
Both because of the importance ofPMN in can-
didal infections and because of their apparent sus-
ceptibility to gliotoxin, we sought to identify func-
tional alterations in gliotoxin-treated PMN. Our
approach involved examining the various elements
of the phagocytic response, including directed mi-
gration, particle engulfment, respiratory increment,
and bactericidal effects. Because of the opportunity
for the interaction between mucosal leukocytes
and mucosal organisms, the inhibition of phagocy-
tosis could play a role in the persistence or recur-
rence of candidiasis. As shown in the present study,
all aspects of phagocytic function were altered to
some degree by incubation with gliotoxin.
The possibility that gliotoxin may have a role in
vaginal infection is dependent on whether the or-
ganism can actually produce the toxin in vivo. In
previous studies we found that gliotoxin can be
produced by Candida inoculated into fluid obtained
on vaginal swabs from patients. 7 We also showed
that women with yeast vaginitis had detectable lev-
els of gliotoxin, and these levels were sufficient to
cause the altered phagocytic function as reported in
the present study. Since we were able to isolate the
gliotoxin from the yeast vaginitis patients, we pre-
dict that it is not degraded but may be neutralized
with the use of antimycotic agent.
While this investigation suggests a potential role
for gliotoxin in mucocutaneous candidiasis, the
mechanism of the deleterious effects on phagocytic
function was not directly investigated. Several ob-
servations may be enlightening with regard to the
potential role of gliotoxin in vivo. Engulfment of
particles requires ligation of the particles to the
phagocyte followed by membrane invagination.
The apparent structural changes in leukocytes as
shown by flow cytometry in concert with micro-
scopic observation of cell blebbing (data not
shown) suggest that membrane changes that de-
crease the effectiveness of particle ingestion may
occur in response to gliotoxin exposure. Sporides-
min, another fungal toxin that is a chemical conge-
ner of gliotoxin, has been reported to cause disap-
pearance of liver cell microvilli, 11 further suggest.
ing membrane perturbation among compounds of
this type. Clearly, more definitive studies in this
area are warranted.
Several investigators have suggested mecha-
nisms whereby gliotoxin exerts its immunosup-
pressive effects, and these theories provide a good
basis for a more mechanistic study of biological
activity. For example, the disulfide component of
gliotoxin could cross link membrane receptors.
Pettyz indicated that there may be a disulfide link
between Fc receptors for antibody, and the inter-
polation of gliotoxin between these receptors could
alter the ability to trigger appropriate phagocytic
activity.
Moreover, this study suggested that while glio-
toxin is able to reduce the respiratory burst activity
of stimulated PMN, the toxin alone in the absence
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Fig. 7. Superoxide production by gliotoxin-treated (I pg/mL) PMN. Gliotoxin-treated .a.) and untreated (B) cells were
stimulated with phorbol myristate. Superoxide was measured spectrophotometrically (570 nm) by cytochrome C reduction
in the presence and absence of superoxide dismutase. This study was conducted in triplicate with PMN collected from two
healthy human donors.
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Fig. 8. Intracellular killing of E. coli by gliotoxin-treated (!
IJg/mL) PMN. Intracellular killing of E. coli by gliotoxin-
treated (GT) and untreated PMN was determined by dif-
ferential centrifugation technique.
of a stimulant caused a relatively slight increment
in NBT reduction (Fig. 6), indicating that inappro-
priate or gratuitous receptor triggering may result
from interaction ofPMN with gliotoxin. Such pos-
sibility was further undiscovered by the finding
that gliotoxin-treated PMN released lactoferrin
(data not shown), implying premature degranula-
tion.
A final potential mechanism of gliotoxin action
is induction of apoptosis, a cell process that is not
inconsistent with the above-mentioned mecha-
nisms of cytotoxicity. The observation of mem-
brane changes noted above coupled with reports in
the literature that attribute apoptotic effects to
gliotoxin underscore this as a potential mechanism
of action.
The present study indicates that there may be
hitherto unrecognized reasons why vaginal yeast
infection in some women can be chronic or recur-
rent and provides a new factor that deserves con-
sideration in future studies of this condition.
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